4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001181431-13-044503
CIK 0001369786operating
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 7:19 PM ET
Size
4.5 KB
Accession
0001181431-13-044503
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Sale
Common Stock
2013-08-12$23.69/sh−1,000$23,690→ 21,478 total
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 7:19 PM ET
- Size
- 4.5 KB